Outcomes of Patients with Therapy-Related Myelodysplastic Syndromes (MDS) after Chemoimmunotherapy for Chronic Lymphocytic Leukemia Compared to Patients with De Novo MDS: A Single-Institution Experience

ConclusionHistory of CLL did not independently impact OS in t-MDS patients beyond IPSS-R.
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research